The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans.
about
NMDA receptors and fear extinction: implications for cognitive behavioral therapyCognitive enhancement as a treatment for drug addictionsA role beyond learning for NMDA receptors in reward-based decision-making-a pharmacological study using d-cycloserine.Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related BehaviorA randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder.D-cycloserine in prelimbic cortex reverses scopolamine-induced deficits in olfactory memory in rats.Cognitive enhancers for anxiety disorders.D-cycloserine facilitates socially reinforced learning in an animal model relevant to autism spectrum disordersD-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependenceD-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysisAn N-methyl-D-aspartate receptor agonist facilitates sleep-independent synaptic plasticity associated with working memory capacity enhancementAbnormal hippocampal activation in patients with extensive history of major depression: an fMRI study.Learning increases the survival of newborn neurons provided that learning is difficult to achieve and successful.A controlled trial of the adjunct use of D-cycloserine to facilitate cognitive behavioral therapy outcomes in a cocaine-dependent populationAugmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brainD-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.Sleep-dependent declarative memory consolidation--unaffected after blocking NMDA or AMPA receptors but enhanced by NMDA coagonist D-cycloserine.The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders.Neuroenhancement strategies for psychiatric disorders: rationale, status quo and perspectives.D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity.Neuropsychological characterization of three adolescent females with anti-NMDA receptor encephalitis in the acute, post-acute, and chronic phases: an inter-institutional case series.The NMDA receptor partial agonist d-cycloserine does not enhance motor learningOxytocin selectively facilitates learning with social feedback and increases activity and functional connectivity in emotional memory and reward processing regions.Nicotinic acetylcholine receptors contribute to learning-induced metaplasticity in the hippocampus.Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine.[Neuropsychological Profile and Working Memory in Bipolar Disorder].Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial.A pilot randomized controlled trial of D-cycloserine and distributed practice as adjuvants to constraint-induced movement therapy after stroke.A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers.Noradrenergic-glucocorticoid modulation of emotional memory encoding in the human hippocampus.
P2860
Q24604822-20F27C67-9750-4972-B9CE-0644F5534BD1Q34284329-89313F6E-DD06-42E3-BE84-C459ECD1BEC9Q34357046-1CB0B597-13C0-47C9-ABA6-0700109BF479Q34500045-D04D27AB-55B9-49F2-8C2D-F8CEA8C99598Q34653628-99E53CF5-D104-492E-BEB5-8079D1FB87C3Q34729257-6D8B3994-B37B-4E74-BEDC-010139E66F9EQ34926000-83E3180F-7DAE-4795-AF63-D971AF96D8D4Q35043125-BF5F6614-AFA3-434E-9DDB-5C0556949045Q35189769-25ED8689-6CBC-458D-BD2F-F21B7E565DADQ35536965-A3E8F793-9854-40CF-AE29-98DC27AAA159Q35541703-6D466BAE-CD65-4CDB-A184-CE4868E36023Q35551573-C8EE9D80-1E85-46CF-A75F-54A2465AE969Q35629122-82122D99-7853-4CA5-83A4-82C507F85FD9Q35787874-3788BA24-06B5-4EBB-BFCC-2669F69FD810Q36005220-2EB46B01-E08E-4707-BF37-693F3A54894EQ36394299-98156C09-B421-4B10-82ED-E1E7C98E2FA2Q36712113-E4CA03D0-E3E1-40E5-A434-204BE50E3A00Q37309767-CB4A390C-2EB2-4F7E-A5AB-DD8AE114D03AQ37318862-5F755C62-B512-47DC-932D-295537359D4AQ38038979-AEB3155E-2792-4FD1-90E2-33AB652D31E5Q38750121-46B12B08-BB13-4E63-AE96-04CC3019D10CQ38862497-D6067024-CAC9-481B-8284-6FE4CFC9F9F4Q41476154-E3BDA131-3B24-4FB1-A75F-15812FBB9AC1Q47438910-30D1B709-A988-46D1-86F9-98ED0E958EDAQ48135473-0A970610-FA8F-4166-98F0-FBA9072F7634Q48621584-B28825D5-4CDF-4F7D-82B8-B1036DC5C16DQ49545326-F33DD1E0-778F-4FFA-8AD9-F13D0DEF1982Q50628293-64DEA1CA-67F1-4A85-99DB-6EAB0AAD60A4Q50667521-18C90B71-58AE-4182-B76D-9918F1666FA0Q50695785-14A24E24-3F8A-40B3-A080-08DD52CAFD26Q51017961-822488C9-1B39-46F8-ADAF-2BDFC278BF09
P2860
The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The N-methyl-D-aspartate recep ...... ippocampal activity in humans.
@en
The N-methyl-D-aspartate recep ...... ippocampal activity in humans.
@nl
type
label
The N-methyl-D-aspartate recep ...... ippocampal activity in humans.
@en
The N-methyl-D-aspartate recep ...... ippocampal activity in humans.
@nl
prefLabel
The N-methyl-D-aspartate recep ...... ippocampal activity in humans.
@en
The N-methyl-D-aspartate recep ...... ippocampal activity in humans.
@nl
P2093
P50
P1476
The N-methyl-D-aspartate recep ...... hippocampal activity in humans
@en
P2093
Alexandra Patin
David-Marian Otte
Haang Jeung
Oezguer A Onur
Wolfgang Maier
P304
P356
10.1016/J.BIOPSYCH.2010.01.022
P407
P50
P577
2010-03-20T00:00:00Z